Immunovant IMVT
NASDAQ IMVT
$35.64 +0.49 (+1.39%)
As of: Nov 10, 2026 · 1:34 PM EST

Immunovant (IMVT) Assets (2018 - 2026)

Updated

Analysis

Immunovant (IMVT) Assets (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 197.43 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 147.68 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 115.83 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 51.41 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 205.00 Bn
10 Immunovant 7.32 Bn 4.11 Bn - 852.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 852.49 Mn
Mar 31, 2026 957.01 Mn
Dec 31, 2025 1.05 Bn
Sep 30, 2025 582.96 Mn
Jun 30, 2025 661.44 Mn
Mar 31, 2025 776.22 Mn
Dec 31, 2024 420.93 Mn
Sep 30, 2024 515.71 Mn
Jun 30, 2024 589.68 Mn
Mar 31, 2024 666.37 Mn
Dec 31, 2023 711.45 Mn
Sep 30, 2023 292.07 Mn
Jun 30, 2023 351.22 Mn
Mar 31, 2023 405.84 Mn
Dec 31, 2022 456.24 Mn
Sep 30, 2022 428.15 Mn
Jun 30, 2022 458.66 Mn
Mar 31, 2022 515.56 Mn
Dec 31, 2021 543.18 Mn
Sep 30, 2021 566.73 Mn
API Access

Immunovant Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=IMVT&period=max&api_key=YOUR_API_KEY